+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vietnam OTC Consumer Health Products Market, By Type:, By Distribution Channel:: By Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024-2032.

  • PDF Icon

    Report

  • 115 Pages
  • July 2024
  • Region: Vietnam
  • Astute Analytica
  • ID: 5995325
OTC Consumer Health Products Market, By Type: (Wound Care Products, Dermatological Products, Contraceptives, Vitamins & Dietary Supplements, Ophthalmology Products, Gastrointestinal Products and Others), By Distribution Channel: (Online and Offline): By Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024-2032.

Vietnam OTC Consumer Health Products Market Forecast till 2032: Set to Reach US$ 5.25 Billion by 2032 with a CAGR of 8.67%

Market Introduction:

The Vietnam OTC Consumer Health Products Market is experiencing robust expansion, valued at US$ 2.54 billion in 2023 and projected to grow at a CAGR of 8.67% from 2024 to 2032.

The OTC (over-the-counter) consumer health products market encompasses a diverse range of non-prescription medications and wellness items available directly to consumers without the need for a healthcare provider’s prescription. These products include pain relievers, cold and flu remedies, dietary supplements, vitamins, and personal care items. The convenience, accessibility, and increasing consumer awareness about health and wellness drive the growth of this market. With a focus on self-care and preventative health, OTC products cater to a wide array of everyday health needs and minor ailments, empowering individuals to manage their well-being more proactively. Innovations in product formulations, coupled with rising health consciousness and aging populations, continue to shape the OTC market, making it a dynamic and expanding segment within the broader healthcare industry.

Growth Influencers:

Vietnam's OTC consumer health products market is experiencing dynamic growth, fueled by rising disposable incomes and heightened health awareness. The country's economic progress, with GDP per capita increasing from $3,586.3 in 2020 to $4,163.5 in 2022 and an impressive GDP growth rate of 8.0% in 2022, has elevated consumer spending, particularly in health and wellness. As the middle-income and affluent segments expand, there is a notable shift towards proactive health management, driven by increased awareness of health risks and preventive measures. The $23 billion healthcare expenditure in 2022 reflects this prioritization. Access to health information via online platforms and social media, coupled with the COVID-19 pandemic, has amplified demand for OTC products like vitamins, dietary supplements, and pain relievers. Foreign brands are gaining traction due to their perceived premium quality. Additionally, Vietnam's rapidly aging population, with a significant rise in those aged 65 and older, is further propelling market demand. Older adults are increasingly investing in OTC products for joint health, bone density, and chronic condition management, such as diabetes and cardiovascular health. Pharmacies play a critical role in this market, providing essential advice and product access, especially for the elderly. Overall, the combination of economic growth, rising health consciousness, and an aging population presents substantial opportunities for the OTC health products market in Vietnam, highlighting the potential for businesses to cater to evolving consumer needs and enhance overall well-being.

Segment Overview:

The OTC Consumer Health Products market is categorized based on Type and Distribution Channel.

By Type

  • Wound Care Products
  • Dermatological Products
  • Contraceptives
  • Vitamins & Dietary Supplements
  • Ophthalmology Products
  • Gastrointestinal Products
  • Others

By Distribution Channel

  • Online
  • Offline
  • Pharmacies
  • Convenience Stores
In the OTC consumer health products market, the "Others" segment leads with a 24.48% market share in 2023. This segment encompasses a diverse range of non-prescription pharmaceuticals, including analgesics, hand sanitizers, and sleeping aids. The prominence of this segment highlights consumers’ preference for a variety of OTC solutions to address different health needs, reflecting the broader dynamics and expansion of the market. On the other hand, the Vitamins and Dietary Supplements segment is projected to achieve the highest compound annual growth rate (CAGR) of 9.22% during the forecast period. This growth is driven by increasing interest in preventive healthcare, wellness trends, and greater awareness of nutritional benefits. Consumers’ growing focus on maintaining health and well-being is fueling the demand for these products, contributing to the segment's anticipated high growth rate in the coming years.

Based on distribution channel, the OTC consumer health products market is split between Online and Offline channels. The Offline segment, which includes pharmacies, drugstores, and supermarkets, commands a significant 68.46% share in 2023. This dominance indicates that traditional retail outlets remain the primary source for OTC products. However, the Online segment is expected to experience the highest CAGR of 9.93% over the forecast period. The surge in e-commerce popularity, driven by the convenience of browsing and purchasing products online, is propelling this growth. As online shopping platforms improve and offer a more user-friendly experience, consumers are increasingly turning to digital channels for their OTC needs, suggesting a shift towards online purchasing trends in the future.

Competitive Landscape:

The OTC Consumer Health Products market is characterized by a vigorous competitive landscape, with prominent entities like GlaxoSmithKline, Pfizer, Johnson & Johnson, Bayer AG, Sanofi, Reckitt Benckiser (RB), Abbott, Procter & Gamble, Taisho Pharmaceutical Holdings Co., Ltd.Glenmark and Others. at the forefront, collectively accounting for more than 60% of the overall market share. This competitive milieu is fueled by their intensive efforts in research and development as well as strategic partnerships and collaborations, underscoring their commitment to solidifying market presence and diversifying their offerings. The primary competitive factors include pricing, product caliber, and technological innovation. As the OTC Consumer Health Products industry continues to expand, the competitive fervor among these key players is anticipated to intensify. The impetus for ongoing innovation and alignment with evolving customer preferences and stringent regulations is high. The industry's fluidity anticipates an uptick in novel innovations and strategic growth tactics from these leading corporations, which in turn propels the sector's comprehensive growth and transformation.

Report Insights:

  • Vietnam’s OTC consumer health products market is projected to reach $5.25 billion by 2032, growing at a CAGR of 8.67%.
  • The market, valued at $2.54 billion in 2023, reflects robust expansion driven by rising incomes and health awareness.
  • Economic growth and rising disposable incomes are significantly boosting consumer spending on OTC health products.
  • The OTC market is characterized by intense competition among major players like GlaxoSmithKline and Pfizer.

Questions to be Answered:

  • What is the estimated growth rate of the OTC Consumer Health Products market?
  • What are the key drivers and potential restraints?
  • Which market segments are expected to witness significant growth?
  • Who are the leading players in the market?

Table of Contents

Chapter 1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
Chapter 2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Sources
2.2. Quantitative Research
2.2.1. Primary & Secondary Sources
2.3. Breakdown of Primary Research Respondents, By Country
2.4. Assumption for the Study
2.5. Market Size Estimation
2.6. Data Triangulation
Chapter 3. Executive Summary: Vietnam OTC Consumer Health Products Market
Chapter 4. Vietnam OTC Consumer Health Products Market Overview
4.1. Industry Value Chain Analysis
4.1.1. Material Provider
4.1.2. Manufacturer
4.1.3. Distributor
4.1.4. End User
4.2. Industry Outlook
4.2.1. Global Over-The-Counter (OTC) Medicines Retail Sales (USD Billion), 2020-2022
4.2.2. Vietnam Vitamin and Dietary Supplements Market Overview
4.2.3. Pharmaceutical and OTC Products Regulations and Registration in Vietnam
4.3. PESTLE Analysis
4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.1.1. Rising Awareness of Lifestyle Diseases
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends
4.6. COVID-19 Impact Assessment on Market Growth Trend
4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2019-2032
4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2022
4.8.3. Competitor Mapping & Benchmarking
Chapter 5. Vietnam OTC Consumer Health Products Market Analysis, By Type
5.1. Key Insights
5.2. Market Size and Forecast, 2019-2032 (US$ Mn)
5.2.1. Wound Care Products
5.2.2. Dermatological Products
5.2.3. Contraceptives
5.2.4. Vitamins & Dietary Supplements
5.2.5. Ophthalmology Products
5.2.6. Gastrointestinal Products
5.2.7. Others
Chapter 6. Vietnam OTC Consumer Health Products Market Analysis, By Distribution Channel
6.1. Key Insights
6.2. Market Size and Forecast, 2019-2032 (US$ Mn)
6.2.1. Online
6.2.2. Offline
6.2.2.1. Pharmacies
6.2.2.2. Convenience Stores
Chapter 7. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
7.1. Abbott Laboratories
7.2. Bayer AG
7.3. Danone
7.4. GSK plc
7.5. Johnson and Johnson
7.6. Pfizer Inc.
7.7. Reckitt Benckiser Group PLC
7.8. Sanofi SA
7.9. Taisho Pharmaceutical Holdings Co., Ltd.
7.10. The Procter & Gamble Company
7.11. Other Prominent Players

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Bayer AG
  • Danone
  • GSK plc
  • Johnson and Johnson
  • Pfizer Inc.
  • Reckitt Benckiser Group PLC
  • Sanofi SA
  • Taisho Pharmaceutical Holdings Co., Ltd.
  • The Procter & Gamble Company

Table Information